Mariam Eatedali on Department of Health and Human Services (HHS)

Washington Healthcare Update - May 2020 #4

This week in Washington: The House and Senate are out of session for Memorial Day Weekend. The House returns Wednesday, May 27....more

5/27/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicare , Medicare Part D , Nursing Homes

Washington Healthcare Update - May 2020 #3

This week in Washington: House hearing on the response to COVID-19 by the Department of Veterans Affairs; Senate hearing on caring for seniors amid the COVID-19 crisis....more

5/19/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Food and Drug Administration (FDA) , GAO , Trump Administration

Washington Healthcare Update - May 2020 #1

This week in Washington: Senate returns to session, Rep. Pallone lays out legislative priorities for COVID-19 response as House delays return to Washington....more

5/5/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , OMB

Washington Healthcare Update - April 2020 #4

This week in Washington: Congress passes $484 billion COVID-19 package, with $321 billion for the Paycheck Protection Program; Supreme Court rules for commercial health insurers in $12 billion risk corridors case....more

4/28/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Trump Administration

Washington Healthcare Update - April 2020 #3

This week in Washington: The House plans to reconvene May 4, Senate Democrats request information from Kushner on health data collection....more

4/21/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , OMB

Washington Healthcare Update - April 2020 #2

This week in Washington: The Senate reconvenes April 13 to continue negotiations on the next COVID-19 stimulus package; the House is expected to reconvene April 20....more

4/14/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Telehealth , Trump Administration

Washington Healthcare Update - April 2020 #1

This week in Washington: The Senate and the House are not scheduled to return to the Hill until the week of April 20 and are currently in a district work period....more

4/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , MACPAC

Washington Healthcare Update - March 2020 #4

This week in Washington: Congress debates additional legislation to address the coronavirus (COVID-19) pandemic. ...more

3/24/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , Prescription Drugs , Trump Administration

Washington Healthcare Update - March 2020 #3

This week in Washington: House passes Families First Coronavirus Response Act, legislation moves to Senate; CMS releases guidance and information on COVID-19....more

3/17/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid

Washington Healthcare Update - March 2020 #2

This week in Washington: CMS develops additional code for coronavirus lab tests, announces actions to address spread of coronavirus; House passes bill to ban e-cigarette flavors; Grassley says updated Senate Finance drug...more

3/10/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , E-Cigarettes , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - March 2020 #1

This week in Washington: Hearings scheduled on the U.S. response to the Coronavirus. ...more

3/3/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Advantage , Pharmaceutical Industry

Washington Healthcare Update - February 2020 #4

Upcoming Hearings/Markups - Wednesday, February 26, 2020 - House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: “Department of Health and Human Services...more

2/25/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicare , Medicare Advantage , Medicare Part D , Prescription Drugs

Washington Healthcare Update - February 2020 #3

This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more

2/18/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicaid , Medicare , Medicare Advantage , Medicare Part D , Trump Administration

Washington Healthcare Update - February 2020 #2

This week in Washington: Senate to hold hearing on home healthcare in rural America, House to hold hearing on protecting women's access to reproductive healthcare....more

2/11/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Part D , Opioid , Prescription Drugs , Trump Administration

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

2/4/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Advantage , Trump Administration

Washington Healthcare Update - January 2020 #4

This week in Washington: Both the House and Senate are back in session....more

1/28/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Generic Drugs , Health Insurance Portability and Accountability Act (HIPAA) , Medicaid , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - January 2020 #1

Wednesday, Jan. 8, 2020 - House Committee on Energy and Commerce: “Legislation to Improve Americans’ Health Care Coverage and Outcomes” - The Subcommittee on Health of the Committee on Energy and Commerce will hold a...more

1/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #3

This Week in Washington: The House and Senate are out of session until the new year. Congress - House - House Passes USMCA Trade Deal ...more

12/24/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Impeachment , Individual Mandate , OIG , Outpatient Prospective Payment System (OPPS) , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Washington Healthcare Update - December 2019 #2

This Week in Washington: The House and Senate will leave for the holidays by Dec. 20....more

12/17/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #1

This Week in Washington: The House and Senate are back from Thanksgiving recess. Congress is expected to be in session until or about Dec. 20....more

12/10/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Safe Harbors , Stark Law , Trump Administration

Washington Healthcare Update - November 2019 #4

This week in Washington: The House and Senate are out for Thanksgiving recess this week. Congress - Hearings/Markups - House Committee on the Judiciary: “The Patent Trial and Appeal Board and the Appointments Clause:...more

11/26/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Draft Guidance , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Prescription Drugs , Transparency

Washington Healthcare Update - November 2019 #3

This week in Washington: Senate to hold a confirmation hearing for Dr. Stephen Hahn, Trump's nominee to be the new FDA commissioner, as well as a hearing on Alzheimer's awareness. ...more

11/19/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Self-Referral , Stark Law

Washington Healthcare Update - November 2019 #1

This week in Washington: Senate to hold a hearing on the response to lung illness and rising youth electronic cigarette use, as well as a hearing on protecting veterans from a variety of scams, including fake charities....more

11/5/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicaid , OIG , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

House Committees Bring Pelosi's Drug Bill to Floor; Action Expected by Late November

In keeping with U.S. House Speaker Nancy Pelosi’s schedule for pushing H.R. 3, the Lower Drug Costs Now Act, through the House of Representatives, the three committees of jurisdiction held mark-ups and passed the proposal, as...more

10/30/2019 / Department of Health and Human Services (HHS) , Drug Pricing , Employee Retirement Income Security Act (ERISA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Section 340B

Washington Healthcare Update - October 2019 #3

This week in Washington: House to hold a markup of five healthcare bills, as well as a hearing to seek clarity on the Trump administration's health care policy choices; Senate to discuss solutions to the substance misuse...more

10/22/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , GAO , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , MACPAC , Medicare , OIG , Open Enrollment , Pharmaceutical Industry , Physicians , Prescription Drugs , SAMHSA , Self-Referral , Stark Law , Trump Administration

Mariam Eatedali

McGuireWoods LLP

Popular Topics by This Author

Latest Posts › Department of Health and Human Services (HHS)